Format

Send to

Choose Destination
Nanomaterials (Basel). 2019 Apr 15;9(4). pii: E615. doi: 10.3390/nano9040615.

A Suite of Therapeutically-Inspired Nucleic Acid Logic Systems for Conditional Generation of Single-Stranded and Double-Stranded Oligonucleotides.

Author information

1
RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. paul.zakrevsky@nih.gov.
2
Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. eckart@mail.nih.gov.
3
RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. hadley.humbertson@nih.gov.
4
Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. mathias.viard@nih.gov.
5
RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. nomiko.d@gmail.com.
6
RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shapirbr@mail.nih.gov.

Abstract

Several varieties of small nucleic acid constructs are able to modulate gene expression via one of a number of different pathways and mechanisms. These constructs can be synthesized, assembled and delivered to cells where they are able to impart regulatory functions, presenting a potential avenue for the development of nucleic acid-based therapeutics. However, distinguishing aberrant cells in need of therapeutic treatment and limiting the activity of deliverable nucleic acid constructs to these specific cells remains a challenge. Here, we designed and characterized a collection of nucleic acids systems able to generate and/or release sequence-specific oligonucleotide constructs in a conditional manner based on the presence or absence of specific RNA trigger molecules. The conditional function of these systems utilizes the implementation of AND and NOT Boolean logic elements, which could ultimately be used to restrict the release of functionally relevant nucleic acid constructs to specific cellular environments defined by the high or low expression of particular RNA biomarkers. Each system is generalizable and designed with future therapeutic development in mind. Every construct assembles through nuclease-resistant RNA/DNA hybrid duplex formation, removing the need for additional 2'-modifications, while none contain any sequence restrictions on what can define the diagnostic trigger sequence or the functional oligonucleotide output.

KEYWORDS:

RNA; RNA logic; conditional activation; functional RNA; nucleic acid therapeutic

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center